These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6331651)

  • 1. Mitogenic activity of the epidermal growth factor receptor after transfer from A431 carcinoma cells to receptor-negative fibroblastic cells.
    Das M; Biswas R; Basu M; Bishayee S
    Cancer Res; 1984 Aug; 44(8):3539-45. PubMed ID: 6331651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
    Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
    Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-receptor-protein kinase interactions.
    Cohen S; Carpenter G; King L
    Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in the mechanism of growth factor action: activation of protein kinase by epidermal growth factor.
    Soderquist AM; Carpenter G
    Fed Proc; 1983 Jun; 42(9):2615-20. PubMed ID: 6303864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
    Sato JD; Kawamoto T; Le AD; Mendelsohn J; Polikoff J; Sato GH
    Mol Biol Med; 1983 Dec; 1(5):511-29. PubMed ID: 6094961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody to the human epidermal growth factor receptor.
    Waterfield MD; Mayes EL; Stroobant P; Bennet PL; Young S; Goodfellow PN; Banting GS; Ozanne B
    J Cell Biochem; 1982; 20(2):149-61. PubMed ID: 6188757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.
    Kamata N; Chida K; Rikimaru K; Horikoshi M; Enomoto S; Kuroki T
    Cancer Res; 1986 Apr; 46(4 Pt 1):1648-53. PubMed ID: 3004701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor-induced stimulation of epidermal growth factor-receptor synthesis in human cytotrophoblasts and A431 carcinoma cells.
    DePalo L; Das M
    Cancer Res; 1988 Mar; 48(5):1105-9. PubMed ID: 3257711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor.
    Lifshitz A; Lazar CS; Buss JE; Gill GN
    J Cell Physiol; 1983 Jun; 115(3):235-42. PubMed ID: 6304117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression.
    Sizemore N; Rorke EA
    Cancer Res; 1993 Oct; 53(19):4511-7. PubMed ID: 8402622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.
    Merlino GT; Xu YH; Richert N; Clark AJ; Ishii S; Banks-Schlegel S; Pastan I
    J Clin Invest; 1985 Mar; 75(3):1077-9. PubMed ID: 2984254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the epidermal growth factor receptor during internalization in A-431 cells.
    Nesterov A; Lysan S; Vdovina I; Nikolsky N; Fujita DJ
    Arch Biochem Biophys; 1994 Sep; 313(2):351-9. PubMed ID: 8080283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor.
    Roy LM; Gittinger CK; Landreth GE
    J Cell Physiol; 1991 Jan; 146(1):63-72. PubMed ID: 1990020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor-dependent phosphorylation of lipocortin.
    Pepinsky RB; Sinclair LK
    Nature; 1986 May 1-7; 321(6065):81-4. PubMed ID: 3010133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
    Faaland CA; Laskin JD; Thomas TJ
    Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor action as a model for lymphokine function.
    Das M
    Fed Proc; 1982 Jun; 41(8):2484-9. PubMed ID: 6282657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.